$3.92
0.225.95%
At Close: -
$3.70
-0.22-5.61%
After Hours: Sep 5, 7:43 PM EDT
15 minutes delayed
Comments
Loading...
Lumos Pharma (LUMO) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestLumos Pharma (NASDAQ:LUMO) Stock Quotes, Forecast and News Summary
Lumos Pharma Stock (NASDAQ: LUMO) stock price, news, charts, stock research, profile.
| Open | $3.92 |
| Close | $3.92 |
| Volume / Avg. | 23.33K / 79.13K |
| Day Range | $3.91 - $4.03 |
| 52 Wk Range | 1.37 - 4.55 |
| Market Cap | $31.82M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 65 |
| Short Interest | 5.39% |
| Days to Cover | 1.28 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Lumos Pharma Inc
Sector
Health Care
Industry
Biotechnology
Lumos Pharma Inc is a biopharmaceutical company that develops treatments for cancer and rare disease...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Lumos Pharma (LUMO) stock?
You can purchase shares of Lumos Pharma (NASDAQ:LUMO) through any online brokerage.
Who are Lumos Pharma (LUMO) competitors?
Other companies in Lumos Pharma’s space includes: Estrella Immunopharma (NASDAQ:ESLA), Acurx Pharmaceuticals (NASDAQ:ACXP), Curis (NASDAQ:CRIS), Palatin Techs (AMEX:PTN) and Longeveron (NASDAQ:LGVN).
What is the forecast, or price target, for Lumos Pharma (LUMO) stock?
Lumos Pharma has a consensus price target of $14.50.
What is the current price for Lumos Pharma (LUMO)?
The stock price for Lumos Pharma (NASDAQ: LUMO) is $3.7 last updated September 5, 2024 at 7:43 PM EDT.
Does Lumos Pharma (LUMO) pay a dividend?
There are no upcoming dividends for Lumos Pharma.
When is Lumos Pharma (NASDAQ:LUMO) reporting earnings?
Lumos Pharma’s Q3 earnings are confirmed for Tuesday, November 5, 2024.
Is Lumos Pharma (LUMO) going to split?
There is no upcoming split for Lumos Pharma.
What sector and industry does Lumos Pharma (LUMO) operate in?
Lumos Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.